This study focuses on individuals experiencing a coma caused by an acute brain injury, which is a sudden and severe damage to the brain. The purpose of the study is to see if a specific medication can help patients wake up sooner. The treatment being tested is methylphenidate, which is given by mouth every day. Some participants will receive the active medication, while others will receive a placebo.

During the trial, participants are assigned to different groups to compare the effects of the medication against the placebo. The process involves monitoring how long it takes for a person to show signs of regained consciousness, which is the ability to be awake and aware of their surroundings. The study tracks how quickly patients respond to the treatment and observes their overall recovery and health status during their stay in the intensive care unit.